Search
Now showing items 1-2 of 2
Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes
(
Wolters Kluwer Health, Inc
, 2016 , Article)
Background: The biodegradable polymer drug-eluting stents (DES) were developed to improve vascular healing. However, further data and longer-term follow-up are needed to confirm safety and efficacy of these stents. This ...
Solely abluminal drug release from coronary stents could possibly improve reendothelialization
(
John Wiley and Sons Inc.
, 2016 , Article)
Objectives
To compare a new stent with an asymmetric coating, eluting the drug to the abluminal surface, to a stent with a conventional coating eluting the drug both to the luminal and the abluminal side.
Background
Stents ...